Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Survival Tree

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a survival tree begins...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

The Mantel-Cox Log-Rank Test

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

RMD open·2017

Same author

Reply: To PMID 25989470.

Arthritis & rheumatology (Hoboken, N.J.)·2015

Same author

Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.

Arthritis & rheumatology (Hoboken, N.J.)·2015

Same author

Lifelong physical activity in maintaining bone strength in older men and women of the Age, Gene/Environment Susceptibility-Reykjavik Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012

Same author

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Journal of neuro-oncology·2011

Same journal

A Repeated Block Perturbation Subsampling for Large-Scale Longitudinal Data.

Journal of statistical theory and practice·2026

Same journal

Estimating Baseline Survival Function in the Proportional Hazards Model Under Monotone Hazards.

Journal of statistical theory and practice·2026

Same journal

Enhancing Team Science by Training Collaborative Biostatisticians to have a Strong Statistical Voice.

Journal of statistical theory and practice·2025

Same journal

A Statistical Analysis Plan Template for Observational Studies: Promoting Quality and Rigor in Research.

Journal of statistical theory and practice·2025

Same journal

More than presence-absence; modelling (e)DNA concentration across time and space from qPCR survey data.

Journal of statistical theory and practice·2025

Same journal

A Weighted Survival Regression Framework for Incorporating External Prediction Information.

Journal of statistical theory and practice·2025

See all related articles

Search research articles

Related Experiment Video

Updated: May 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Evaluating a New Risk Marker's Predictive Contribution in Survival Models.

M Liu¹, A S Kapadia, C J Etzel

¹Department of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030.

Journal of Statistical Theory and Practice

|September 18, 2012

Summary

This summary is machine-generated.

This study introduces time-dependent net reclassification improvement (NRI) and integrated discrimination improvement (IDI) for survival models. These new measures better assess risk markers in time-to-event data compared to existing methods.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Related Experiment Videos

Last Updated: May 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Area of Science:

Biostatistics
Epidemiology
Clinical Research

Background:

Area under the receiver operating characteristic curve (AUC) is a common performance metric for prediction models.
Existing metrics like net reclassification improvement (NRI) and integrated discrimination improvement (IDI) have limitations with time-to-event data.
Evaluating new risk markers in prognostic models requires methods that account for time-dependent outcomes and censoring.

Purpose of the Study:

To extend existing NRI and IDI metrics to time-to-event settings.
To develop sample estimators and asymptotic tests for these new time-dependent metrics.
To compare the performance of time-dependent NRI and IDI against traditional methods for assessing risk marker discrimination.

Main Methods:

Development of novel NRI and IDI formulations for time-to-event data.
Derivation of statistical estimators and hypothesis tests for the proposed metrics.
Conducting simulation studies to evaluate the performance of the new metrics.

Main Results:

The proposed time-dependent NRI and IDI effectively measure improved discriminatory power in survival models.
Simulation results indicate superior performance of time-dependent NRI and IDI over traditional NRI and IDI for time-to-event outcomes.
The derived estimators and tests provide a robust framework for evaluating prognostic markers.

Conclusions:

Time-dependent NRI and IDI are valuable extensions for assessing risk marker utility in survival analysis.
These new metrics address the limitations of existing methods when dealing with censored time-to-event data.
The findings support the use of time-dependent NRI and IDI for more accurate discrimination assessment in prognostic research.